Judith Feinberg

Judith Feinberg

Associate Chair of Medicine for Faculty Development, Professor of Clinical Medicine

Professional Summary

Dr. Feinberg is nationally recognized for her clinical research in HIV infection and its opportunistic complications, and for her expertise in designing and conducting multicenter treatment trials. Dr. Feinberg is the Co-Principal Investigator of the NIH-funded AIDS Clinical Trials Unit at the University of Cincinnati. She is board certified by the American Board of Internal Medicine and Infectious Diseases. Dr. Feinberg's published works include approximately 98 original publications, 125 abstracts, and 10 book chapters.  She is ... Associate Editor of AIDS Clinical Care, published by Masssachusetts Medical Society.  She has also served as Associate Editor of the American Academy of HIV Medicine Self-Directed Study Guide (over 700 pages, 2003; revised, 2007 & 2012). She serves as reviewer for 18 prestigious journals. Dr. Feinberg has been elected to membership in the American College of Physicians (Fellow), Infectious Diseases Society of America (Fellow), American Society for Microbiology, American Association for the Advancement of Science, International AIDS Society, International Society for Antiviral Research, Society for Clinical Trials, HIV Medical Association, and the American Academy of HIV Medicine (for which she serves as President of the Great Lakes Chapter and as Past Chair of the Board of Directors).  She has served on numerous federal panels and taskforces, includign the FDA's Antiviral Drugs Advisory Panel, and the panels for the Guidelines on preventing mother-to-child transmission of HIV and for preventing and treating HIV-associated opportunistic infections.

Education

Medical Degree, Rush Medical College 1979

Premedical Coursework, University of California 1975

Doctoral Degree Candidate, University of Chicago 1971 (Russian Intellectual History)

Bachelor's Degree, University of Chicago 1967 (Russian Civilization)

Residency , Rush Presbyterian-St. Luke's Medical Center 1982

Fellowship , University of California at Los Angeles 1984 (Infectious Diseases)

Positions and Work Experience

2006 -To Present Associate Chair of Medicine for Faculty Development, University of Cincinnati College of Medicine, Cincinnati, OH

2000 -To Present Professor of Medicine, (tenured), University of Cincinnati College of Medicine, Cincinnati, OH

1999 -2000 Professor of Clinical Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

1995 -1999 Associate Professor of Clinical Medicine, University of Cincinnati College of Medicine, Cincinnati, OH

1995 -2000 Associate Director, Infectious Diseases Center, University of Cincinnati College of Medicine, Cincinnati, OH

1995 -1996 Chair, Coordinating Committe on Therapeutics, Office of AIDS Research, National Institutes of Health, Bethesda, MD

1995 - Associate Professor of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD

1990 -1995 Assistant Professor of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD

1990 - Group Leader, Medical Branch, Treatment Research Program, Division of AIDS, National Institute of Allergy & Infectious Diseases, Bethesda, MD

1987 -1990 Section Head, Medical Branch, Treatment Research Program, Division of AIDS, National Institute of Allergy & Infectious Diseases, Bethesda, MD

1986 -1987 Medical Officer, Treatment Branch, AIDS Program, National Institute of Allergy & Infectious Diseases, Bethesda, MD

1984 -1986 Associate Director, Clinical Research, Schering Plough Corporation, Kenilworth, NJ

Research and Practice Interests

Clinical Research In HIV/AIDS With Focus On Antiretroviral Therapy, HIV Resistance And HIV In Women

UC Health Clinical Focus

Infectious Disease

Certifications

American Board of Internal Medicine (Infectious Disease)

11/13/1984

American Board of Internal Medicine

09/15/1982

Research Support

Grant: #AI 069513 2007 -2013 AIDS Clinical Trials Unit Role:P.I. 2007-2009; Co-P.I. 2009-2013 $1.448 million/year

Grant: #U01 AI052748-02 Investigators:Sherman, Kenneth 2003 -2008 Solid Organ Transplantation in HIV: Multiple-Site Study

Grant: #R01 AI065256 Investigators:Sherman, Kenneth 2006 -2010 Antiretroviral Therapy and the Hepatitis C Virus

Grant: #AI 25897 1998 -2006 AIDS Clinical Trials Unit Role:P.I. $1.8 million/year

Grant: #1 R01 AT01147 Investigators:Tsevat, Joel 2000 -2004 NIH/NCCAM HIV and Spirituality $306,095

Grant: #R01 Investigators:Griffiths, Paul 1997 -1999 Imminent Markers of CMV Disease

1990 -1996 Johns Hopkins University AIDS Clinical Trials Unit Role:Co-P.I.

Grant: #5-U01-AI-41535-04-A0-S0-E0 Investigators:Feinberg, Judith 07-01-2000 -06-30-2002 National Institute of Allergy and Infectious Diseases Immunology & Molecular Virology of Acute HIV Infection: HIVNET Role:PI $30,000.00 Closed Level:Federal

Grant: #5-R01-AI-41687-03-A0-S0-E0 Investigators:Feinberg, Judith 09-01-1997 -08-31-2000 National Institute of Allergy and Infectious Diseases Laboratory Markers of Imminent Cytomegalovirus Disease Role:PI $270,619.00 Closed Level:Federal

Grant: #1-U01-AI-38858-01-A0-S0-E0 Investigators:Feinberg, Judith 12-17-1996 -12-31-2000 National Institute of Allergy and Infectious Diseases ACTG 301 Neurological Assessments Role:PI $152,000.00 Closed Level:Federal

Grant: #BRS-ACURE-S-11-000068-001331 / UM1AI068636-06 Investigators:Feinberg, Judith 06-01-2011 -05-31-2012 National Institute of Allergy and Infectious Diseases AIDs Clinical Trial Group Network AEC Member Role:PI $12,000.00 Closed Level:Federal

Grant: #CHN Sub \ H76HAO0111 Investigators:Feinberg, Judith; Fichtenbaum, Carl; Forrester, Jennifer; Grubbs, Peter; Haglund, Lisa; Johnson, Kay; Kaul, Pamposh 04-01-2012 -03-31-2014 Health Resources and Services Administration Community HIV Comprehensive Care Program Role:Collaborator $1,165,506.00 Active Level:Federal

Grant: #SRS 008170 \ UM1AI068636 Investigators:Feinberg, Judith 06-01-2012 -05-31-2013 National Institute of Allergy and Infectious Diseases Minority HIV Investigator Mentoring Program Role:PI $60,277.00 Active Level:Federal

Grant: #HFGC Grant Agreement Investigators:Feinberg, Judith 12-11-2012 -09-30-2013 Health Foundation of Greater Cincinnati Cincinnati Exchange Planning Project Role:PI $90,045.00 Active Level:Private Non-Profit

Grant: #Grant Agreement Investigators:Feinberg, Judith 12-11-2013 -12-10-2014 Interact For Health Cincinnati Exchange Project Role:PI $50,000.00 Awarded Level:Private Non-Profit

Grant: #Contract # PREV-31176-02 Investigators:Feinberg, Judith 11-08-2013 -06-30-2015 Ohio Department of Health Project DAWN Hamilton County Role:PI $48,000.00 Active Level:State of Ohio

Grant: #110007 / UM1AI068636 Investigators:Feinberg, Judith 01-01-2014 -01-31-2014 National Institute of Allergy and Infectious Diseases AIDS Clinical Trial Group (ACTG)- Executive Committee Role:PI $900.00 Active Level:Federal

Grant: #1U018PS004566-01 Investigators:Feinberg, Judith; Winstanley, Erin 09-30-2014 -09-29-2017 Centers for Disease Control and Prevention Southern Ohio Prevents Hepatitis Project (StOPHeP) Role:PI $299,859.00 Awarded Level:Federal

Grant: #CRB-SSS-S-15-004277 Investigators:Feinberg, Judith 04-01-2015 -09-30-2015 Leidos Biomedical Research, Inc. Subcontract No. CRB-SSS-S-15-004277 Role:PI $5,400.00 Active Level:Industry

Publications

Peer Reviewed Publications

Hicks,C.; Feinberg,J. (2002. )Antiretroviral rounds. "Doc, I've been making mistakes" .AIDS Clinical Care, ,14 (12 ),108 -109

Nokta,M.A.; Holland,F.; De Gruttola,V.; Emery,V.C.; Jacobson,M.A.; Griffiths,P.; Pollard,R.B.; Feinberg,J.E.; AIDS Clinical Trials Group, Protocol 204/GlaxoWellcome 123-014, International CMV Prophylaxis Study Group. (2002. )Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease .The Journal of infectious diseases, ,185 (12 ),1717 -1722

Falloon,J.; Ait-Khaled,M.; Thomas,D.A.; Brosgart,C.L.; Eron Jr,J.J.; Feinberg,J.; Flanigan,T.P.; Hammer,S.M.; Kraus,P.W.; Murphy,R.; Torres,R.; Masur,H.; CNA2007 Study Team. (2002. )HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients .AIDS (London, England), ,16 (3 ),387 -396

Feinberg,J. (2002. )More data on safety of antiretrovirals in pregnancy .AIDS Clinical Care, ,14 (3 ),23

Feinberg,J. (2002. )Promising new agents on the horizon .AIDS Clinical Care, ,14 (3 ),22

Abdool Karim,S.S.; Currier,J.; del Rio,C.; Feinberg,J.; Friedland,G.H.; Sax,P.E.; Zuger,A. (2002. )Report on the XIV International AIDS Conference .AIDS Clinical Care, ,14 (9 ),77 -85

Benson,C.A.; Deeks,S.G.; Brun,S.C.; Gulick,R.M.; Eron,J.J.; Kessler,H.A.; Murphy,R.L.; Hicks,C.; King,M.; Wheeler,D.; Feinberg,J.; Stryker,R.; Sax,P.E.; Riddler,S.; Thompson,M.; Real,K.; Hsu,A.; Kempf,D.; Japour,A.J.; Sun,E. (2002. )Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients .The Journal of infectious diseases, ,185 (5 ),599 -607

Fischl,M.A.; Ribaudo,H.J.; Collier,A.C.; Erice,A.; Giuliano,M.; Dehlinger,M.; Eron,J.J.,Jr; Saag,M.S.; Hammer,S.M.; Vella,S.; Morse,G.D.; Feinberg,J.E.; Denter,L.M.; Eshleman,S.H.; Adult AIDS Clinical Trials Group 388 Study Team. (2003. )A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease .The Journal of infectious diseases, ,188 (5 ),625 -634

Jacobson,D.L.; Wu,A.W.; Feinberg,J.; Outcomes Committee of the Adult AIDS Clinical Trials Group. (2003. )Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease .Journal of clinical epidemiology, ,56 (9 ),874 -879

Greenberg,R.N.; Feinberg,J.; Goodrich,J.; Pilson,R.S.; Siemon-Hryczyk,P. (2003. )Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up .Antiviral Therapy, ,8 (1 ),37 -42

Feinberg,J. (2003. )Report from the Tenth Retrovirus Conference. Resistance .AIDS Clinical Care, ,15 (4 ),33 -34

Feinberg,J.; Japour,A.J. (2003. )Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus infection .Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,36 (2 ),201 -206

King,M.S.; Bernstein,B.M.; Walmsley,S.L.; Sherer,R.; Feinberg,J.; Sanne,I.; Cernohous,P.; Montaner,J.S.; Brun,S.C.; Sun,E. (2004. )Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients .The Journal of infectious diseases, ,190 (2 ),280 -284

Becker,S.; Fusco,G.; Fusco,J.; Balu,R.; Gangjee,S.; Brennan,C.; Feinberg,J.; Collaborations in HIV Outcomes Research/US Cohort. (2004. )HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study .Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,39 Suppl 5 ,S267 -75

Feinberg,J. (2004. )Meeting report from the XV International AIDS Conference. Clinical trials of approved antiretrovirals .AIDS Clinical Care, ,16 (9 ),70 -71

Feinberg,J. (2004. )Meeting report from the XV International AIDS Conference. Perinatal transmission .AIDS Clinical Care, ,16 (9 ),70

Feinberg,J. (2004. )New drugs for HAART. Interview by Vicki Glaser .AIDS Patient Care and STDs, ,18 (11 ),623 -628

Eron,J.J.; Feinberg,J.; Kessler,H.A.; Horowitz,H.W.; Witt,M.D.; Carpio,F.F.; Wheeler,D.A.; Ruane,P.; Mildvan,D.; Yangco,B.G.; Bertz,R.; Bernstein,B.; King,M.S.; Sun,E. (2004. )Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial .The Journal of infectious diseases, ,189 (2 ),265 -272

DiCenzo,R.; Forrest,A.; Fischl,M.A.; Collier,A.; Feinberg,J.; Ribaudo,H.; DiFrancecso,R.; Morse,G.D.; AIDS Clinical Trials Group 388/733/5060 Study Team. (2004. )Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects .Antimicrobial Agents and Chemotherapy, ,48 (3 ),918 -923

Feinberg,J. (2004. )Report from the 11th conference on retroviruses and opportunistic infections. Resistance .AIDS Clinical Care, ,16 (4 ),28 -29

Feinberg,J. (2004. )Report from the 11th conference on retroviruses and opportunistic infections. Studies of approved antiretrovirals .AIDS Clinical Care, ,16 (4 ),26 -27

Collier,A.C.; Ribaudo,H.; Mukherjee,A.L.; Feinberg,J.; Fischl,M.A.; Chesney,M.; Adult AIDS Clinical Trials Group 746 Substudy Team. (2005. )A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy .The Journal of infectious diseases, ,192 (8 ),1398 -1406

Feinberg,J. (2005. )Meeting notes from ICAAC. Prevalence and predictors of R5 and X4 tropism .AIDS Clinical Care, ,17 (1 ),7

Feinberg,J. (2005. )Meeting notes from ICAAC. Promising early results for a novel CCR5 antagonist .AIDS Clinical Care, ,17 (1 ),8

Feinberg,J. (2005. )Meeting notes from ICAAC. Ritonavir-boosted tipranavir proves beneficial in treatment-experienced patients .AIDS Clinical Care, ,17 (1 ),5 -6

Feinberg,J. (2005. )Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC .AIDS Clinical Care, ,17 (1 ),7

Feinberg,J. (2005. )Meeting notes from the 3rd IAS Conference. New drugs .AIDS Clinical Care, ,17 (10 ),96 -97

Feinberg,J. (2005. )Report from the 12th Retrovirus Conference. Studies of approved antiretrovirals .AIDS Clinical Care, ,17 (4 ),34 -35

Feinberg,J. (2005. )Top stories of 2004. Bad nukes comes in threes .AIDS Clinical Care, ,17 (1 ),1

Feinberg,J. (2006. )Adherence: what do our patients think? .IAPAC monthly, ,12 (1 ),12 -15

Cotton,S.; Tsevat,J.; Szaflarski,M.; Kudel,I.; Sherman,S.N.; Feinberg,J.; Leonard,A.C.; Holmes,W.C. (2006. )Changes in religiousness and spirituality attributed to HIV/AIDS: are there sex and race differences? .Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, ,21 Suppl 5 ,S14 -20

Temesgen,Z.; Feinberg,J.E. (2006. )Drug evaluation: bevirimat--HIV Gag protein and viral maturation inhibitor .Current opinion in investigational drugs (London, England : 2000), ,7 (8 ),759 -765

Sherman,S.N.; Mrus,J.M.; Yi,M.S.; Feinberg,J.; Tsevat,J. (2006. )How do patients with HIV/AIDS understand and respond to health value questions? .Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, ,21 Suppl 5 ,S56 -61

Feinberg,J. (2006. )Report from the 13th retrovirus conference. Expanding HIV testing .AIDS Clinical Care, ,18 (4 ),39

Feinberg,J. (2006. )Report from the 13th retrovirus conference. Extending the role of atazanavir .AIDS Clinical Care, ,18 (4 ),38

Feinberg,J. (2006. )Report from the XVI International AIDS Conference. CCR5 inhibitors .AIDS Clinical Care, ,18 (11 ),100 -101

Feinberg,J. (2006. )Report from the XVI International AIDS Conference. Efavirenz for high viral load and low CD4--a secondary analysis of ACTG 5095 .AIDS Clinical Care, ,18 (11 ),99

Cotton,S.; Puchalski,C.M.; Sherman,S.N.; Mrus,J.M.; Peterman,A.H.; Feinberg,J.; Pargament,K.I.; Justice,A.C.; Leonard,A.C.; Tsevat,J. (2006. )Spirituality and religion in patients with HIV/AIDS .Journal of general internal medicine : official journal of the Society for Research and Education in Primary Care Internal Medicine, ,21 Suppl 5 ,S5 -13

Feinberg,J. (2006. )The 10-point inspection, HIV-style: what to check under the hood. Some of the most important tests, and what they mean .Positively aware : the monthly journal of the Test Positive Aware Network, ,Spec No ,11 -14

Feinberg,J. (2006. )The case for expanding human immunodeficiency virus testing .Mayo Clinic proceedings.Mayo Clinic, ,81 (4 ),449 -451

Fischl,M.A.; Collier,A.C.; Mukherjee,A.L.; Feinberg,J.E.; Demeter,L.M.; Tebas,P.; Giuliano,M.; Dehlinger,M.; Garren,K.; Brizz,B.; Bassett,R. (2007. )Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen .AIDS (London, England), ,21 (3 ),325 -333

Fischl,M.A.; Collier,A.C.; Mukherjee,A.L.; Feinberg,J.E.; Demeter,L.M.; Tebas,P.; Giuliano,M.; Dehlinger,M.; Garren,K.; Brizz,B.; Bassett,R. (2007. )Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen .AIDS (London, England), ,21 (3 ),325 -333

Tebas,P.; Zhang,J.; Yarasheski,K.; Evans,S.; Fischl,M.A.; Shevitz,A.; Feinberg,J.; Collier,A.C.; Shikuma,C.; Brizz,B.; Sattler,F.; for the AIDS Clinical Trials Group (ACTG) (2007. )Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s) .Journal of acquired immune deficiency syndromes (1999), ,45 (2 ),193 -200

Currier, Judith; Averitt Bridge, Dawn; Hagins, Debbie; Zorrilla, Carmen D; Feinberg, Judith; Ryan, Robert; Falcon, Ron; Tennenberg, Alan; Mrus, Joseph; Squires, Kathleen (2010. )Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.Annals of internal medicine, ,153 (6 ),349-57

Feinberg, Judith (2009. )Top stories of 2008. HIV incidence in the U.S.: new methods result in a higher estimate. AIDS clinical care, ,21 (1 ),4-5

Feinberg, Judith (2008. )Report from the 15th Retrovirus Conference. Parsing the options from comparative trials of initial antiretroviral therapy. AIDS clinical care, ,20 (4 ),27

Feinberg, Judith (2008. )Revised guidelines for antiretroviral use in pregnant women. AIDS clinical care, ,20 (2 ),11

Tebas, Pablo; Zhang, Jiameng; Yarasheski, Kevin; Evans, Scott; Fischl, Margaret A; Shevitz, Abby; Feinberg, Judith; Collier, Ann C; Shikuma, Cecilia; Brizz, Barbara; Sattler, Fred (2007. )Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).Journal of acquired immune deficiency syndromes (1999), ,45 (2 ),193-200

Feinberg, Judith (2006. )Report from the XVI International AIDS Conference. CCR5 inhibitors. AIDS clinical care, ,18 (11 ),100-1

Feinberg, Judith (2006. )The 10-point inspection, HIV-style: what to check under the hood. Some of the most important tests, and what they mean. Positively aware : the monthly journal of the Test Positive Aware Network, ,Spec No ,11-4

Feinberg, Judith (2006. )Report from the 13th retrovirus conference. Expanding HIV testing. AIDS clinical care, ,18 (4 ),39

Feinberg, Judith (2006. )Report from the 13th retrovirus conference. Extending the role of atazanavir. AIDS clinical care, ,18 (4 ),38

Feinberg, Judith (2006. )Adherence: what do our patients think? .IAPAC monthly, ,12 (1 ),12-5

Feinberg, Judith (2005. )Meeting notes from the 3rd IAS Conference. New drugs. AIDS clinical care, ,17 (10 ),96-7

Feinberg, Judith (2005. )Report from the 12th Retrovirus Conference. Studies of approved antiretrovirals. AIDS clinical care, ,17 (4 ),34-5

Feinberg, Judith (2005. )Meeting notes from ICAAC. Promising early results for a novel CCR5 antagonist. AIDS clinical care, ,17 (1 ),8

Feinberg, Judith (2005. )Meeting notes from ICAAC. Prevalence and predictors of R5 and X4 tropism. AIDS clinical care, ,17 (1 ),7

Feinberg, Judith (2005. )Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC. AIDS clinical care, ,17 (1 ),7

Feinberg, Judith (2005. )Meeting notes from ICAAC. Ritonavir-boosted tipranavir proves beneficial in treatment-experienced patients. AIDS clinical care, ,17 (1 ),5-6

Feinberg, Judith (2005. )Top stories of 2004. Bad nukes comes in threes. AIDS clinical care, ,17 (1 ),1

Becker, Stephen; Fusco, Gregory; Fusco, Jennifer; Balu, Rukmini; Gangjee, Shehnaz; Brennan, Clare; Feinberg, Judith (2004. )HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,39 Suppl 5 ,S267-75

Feinberg, Judith (2004. )Meeting report from the XV International AIDS Conference. Clinical trials of approved antiretrovirals. AIDS clinical care, ,16 (9 ),70-1

Feinberg, Judith (2004. )Meeting report from the XV International AIDS Conference. Perinatal transmission. AIDS clinical care, ,16 (9 ),70

King, Martin S; Bernstein, Barry M; Walmsley, Sharon L; Sherer, Renslow; Feinberg, Judith; Sanne, Ian; Cernohous, Paul; Montaner, Julio S G; Brun, Scott C; Sun, Eugene (2004. )Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients.The Journal of infectious diseases, ,190 (2 ),280-4

Feinberg, Judith (2004. )Report from the 11th conference on retroviruses and opportunistic infections. Resistance. AIDS clinical care, ,16 (4 ),28-9

Feinberg, Judith (2004. )Report from the 11th conference on retroviruses and opportunistic infections. Studies of approved antiretrovirals. AIDS clinical care, ,16 (4 ),26-7

Jacobson, Denise L; Wu, Albert W; Feinberg, Judith (2003. )Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. Journal of clinical epidemiology, ,56 (9 ),874-9

Feinberg, Judith (2003. )Report from the Tenth Retrovirus Conference. Resistance. AIDS clinical care, ,15 (4 ),33-4

Hicks, Charles; Feinberg, Judith (2002. )Antiretroviral rounds. "Doc, I've been making mistakes". AIDS clinical care, ,14 (12 ),108-9

Abdool Karim, Salim S; Currier, Judith; del Rio, Carlos; Feinberg, Judith; Friedland, Gerald H; Sax, Paul E; Zuger, Abigail (2002. )Report on the XIV International AIDS Conference. AIDS clinical care, ,14 (9 ),77-85

Feinberg, Judith (2002. )More data on safety of antiretrovirals in pregnancy. AIDS clinical care, ,14 (3 ),23

Feinberg, Judith (2002. )Promising new agents on the horizon. AIDS clinical care, ,14 (3 ),22

Benson, Constance A; Deeks, Steven G; Brun, Scott C; Gulick, Roy M; Eron, Joseph J; Kessler, Harold A; Murphy, Robert L; Hicks, Charles; King, Martin; Wheeler, David; Feinberg, Judith; Stryker, Richard; Sax, Paul E; Riddler, Sharon; Thompson, Melanie; Real, Kathryn; Hsu, Ann; Kempf, Dale; Japour, Anthony J; Sun, Eugene (2002. )Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.The Journal of infectious diseases, ,185 (5 ),599-607

Falloon, Judith; Ait-Khaled, Mounir; Thomas, Deborah A; Brosgart, Carol L; Eron Jr, Joseph J; Feinberg, Judith; Flanigan, Timothy P; Hammer, Scott M; Kraus, Peter W; Murphy, Robert; Torres, Ramon; Masur, Henry (2002. )HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. AIDS (London, England), ,16 (3 ),387-96

Feinberg, Judith (2012. )Truvada PrEP: Why I Voted "Yes".Annals of internal medicine, ,

Robertson, Jaime; Feinberg, Judith (2012. )Darunavir : a nonpeptidic protease inhibitor for antiretroviral-naive and treatment-experienced adults with HIV infection.Expert opinion on pharmacotherapy, ,13 (9 ),1363-75

Sax, Paul E; Tierney, Camlin; Collier, Ann C; Daar, Eric S; Mollan, Katie; Budhathoki, Chakra; Godfrey, Catherine; Jahed, Nasreen C; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F; Ha, Belinda; Woodward, William C; Feinberg, Judith; Tashima, Karen; Murphy, Robert L; Fischl, Margaret A (2011. )Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.The Journal of infectious diseases, ,204 (8 ),1191-201

Feinberg, Judith (2011. )Management of newly diagnosed HIV infection.Annals of internal medicine, ,155 (7 ),ITC41

Feinberg, Judith It's in your blood. Positively aware : the monthly journal of the Test Positive Aware Network, ,23 (6 ),34-7

Krishnan, S; Wu, K; Smurzynski, M; Bosch, R J; Benson, C A; Collier, A C; Klebert, M K; Feinberg, J; Koletar, S L Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.HIV clinical trials, ,12 (4 ),190-200

Feinberg, Judith; Saag, Michael; Squires, Kathleen; Currier, Judith; Ryan, Robert; Coate, Bruce; Mrus, Joseph (2011. )Health-related quality of life in the gender, race, and clinical experience trial.AIDS research and treatment, ,2011 ,349165

Sherman, Kenneth E; Guedj, Jeremie; Shata, Mohamed Tarek; Blackard, Jason T; Rouster, Susan D; Castro, Mario; Feinberg, Judith; Sterling, Richard K; Goodman, Zachary; Aronow, Bruce J; Perelson, Alan S (2014. )Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.Science translational medicine, ,6 (246 ),246ra98

Clotet, Bonaventura; Feinberg, Judith; van Lunzen, Jan; Khuong-Josses, Marie-Aude; Antinori, Andrea; Dumitru, Irina; Pokrovskiy, Vadim; Fehr, Jan; Ortiz, Roberto; Saag, Michael; Harris, Julia; Brennan, Clare; Fujiwara, Tamio; Min, Sherene (2014. )Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.Lancet, ,383 (9936 ),2222-31

Funderburg, Nicholas T; Andrade, Adriana; Chan, Ellen S; Rosenkranz, Susan L; Lu, Darlene; Clagett, Brian; Pilch-Cooper, Heather A; Rodriguez, Benigno; Feinberg, Judith; Daar, Eric; Mellors, John; Kuritzkes, Daniel; Jacobson, Jeffrey M; Lederman, Michael M (2013. )Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine.PloS one, ,8 (12 ),e83514

Keeshin, Susana W; Feinberg, Judith (2015. )Evaluation of dolutegravir safety for the treatment of HIV-1.Expert opinion on drug safety, ,14 (1 ),141-7

Honors and Awards

2007 Michael Harris Humanitarian Award (initial recipient), Cincinnati

2006 Cincinnati Health Care Hero, fist place in Clinician category

2003 Constance B. Wofsy Women's Health Investigator Award

2001 Selected by peers to be listed in "Best Doctors"

1988 National Institutes of Health Award of Merit

1981 -1982 Pillsbury Fellowship

1980 -1982 Housestaff Representative, Committee on Admissions, Rush Medical College

1979 Janet M. Glasgow Scholarship Achievement Citation of the American Medical Women's Association, Rush Medical College

1978 Alpha Omega Alpha (3rd Year Medical School), Rush Medical College

1976 -1979 Student Representative, Committee on Admissions, Rush Medical College

1967 -1969 New York State Fellow for Advanced College Teaching

1967 General Honors in the College and Honors in Major Field (Russian Civilization), University of Chicago

1967 Woodrow Wilson Fellowship semi-finalist, University of Chicago

Post Graduate Training and Education

06-1982-06-1984 Infectious Diseases Fellow, Instructor of Medicine, University of California, Los Angeles, ,Los Angeles, CA

Keywords

HIV/AIDS ,Pharmacoeconomics(MeSH PhrmEco),Pharmacokinetics(MeSH PhrmKin),Health Care Quality, Access, and Evaluation(MeSH N05),Viruses(MeSH B04),Bacterial Infections and Mycoses(MeSH C01),Virus Diseases(MeSH C02),Parasitic Diseases(MeSH C03),Anti-Infective Agents(MeSH D20),Immunologic and Biological Factors(MeSH D24),Therapeutics(MeSH E02)

Contact Information

Academic - UC Health Holmes Hospital
Room 3112
Cincinnati  Ohio, 45219
Phone: (513)584-6977
Fax: (513)584-6386
judith.feinberg@uc.edu